Just 32.1% of reproductive-age women with rheumatic diseases use any kind of prescription contraception, while at the same time more than 70% use at least one fetotoxic medication, according to findings published in Arthritis Care & Research.
“While over two-thirds of reproductive-age women in the United States actively use contraception, little is known about contraceptive use among young women with rheumatic diseases,” Mehret Birru Talabi, MD, PhD, of the University of Pittsburgh, and colleagues wrote. “In addition to preventing unintended pregnancy, contraception may uniquely benefit these women by delaying pregnancy until their diseases are quiescent. ... As several medications used by women with rheumatic diseases have substantial teratogenic potential, contraception use may also prevent pregnancy until women and their doctors have established an acceptably safe medication regimen.”
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.